Mirati Therapeutics, Inc.

MACQUARIE GROUP LTD

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

60,000

Value ($000)

3,525

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	3,525	0.0%	60,000	12/31/2023
2023 Q3	11/14/2023	2,614	0.0%	60,000	9/30/2023
2023 Q2	10/27/2023	2,168	0.0%	60,000	6/30/2023
2023 Q1	6/1/2023	2,231	0.0%	60,000	3/31/2023
2022 Q4	2/21/2023	2,719	0.0%	60,000	12/31/2022
2022 Q3	11/14/2022	4,264	0.0%	60,638	9/30/2022
2022 Q2	8/17/2022	4,099	0.0%	61,055	6/30/2022
2022 Q1	5/16/2022	5,764	0.0%	70,098	3/31/2022
2021 Q4	2/11/2022	10,241	0.0%	69,810	12/31/2021
2021 Q3	11/12/2021	12,313	0.0%	69,598	9/30/2021
2021 Q2	8/13/2021	11,682	0.0%	72,323	6/30/2021
2021 Q1	5/14/2021	14,008	0.0%	81,774	3/31/2021
2020 Q4	2/16/2021	20,648	0.0%	94,008	12/31/2020
2020 Q3	11/13/2020	19,892	0.0%	119,795	9/30/2020
2020 Q2	8/11/2020	21,141	0.0%	185,171	6/30/2020
2020 Q1	5/15/2020	13,704	0.0%	178,271	3/31/2020
2019 Q4	3/18/2020	22,972	0.0%	178,271	12/31/2019